Tag: HBV

Pharma / Biotech

Long-term virological and adherence outcomes to antiviral treatment in a 4-year cohort chronic HBV study.

Newsemia
Related Articles Long-term virological and adherence outcomes to antiviral treatment in a 4-year cohort chronic HBV study. Antivir Ther. 2019 Dec 04;: Authors: Abreu RM,...
Gastroenterology

High Level of Hepatitis B Core-related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load

Newsemia
Chronic hepatitis B virus (HBV) infection is a risk factor for hepatocellular carcinoma (HCC). Serum levels of HB core-related antigen (HBcrAg) have been associated with...
Latest News

Needle stick injuries are common and can transmit many blood-borne pathogens

Newsemia
Needle stick injuries (NSIs) can transmit more than 20 blood-borne pathogens, including HIV, hepatitis B virus (HBV), hepatitis C virus (HCV) and, more rarely, malaria,...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy